Cowealth Medical China Co.,Ltd. (SHA:603122)
9.79
+0.89 (10.00%)
Last updated: Oct 31, 2025, 11:29 AM CST
Cowealth Medical China Revenue
Cowealth Medical China had revenue of 181.20M CNY in the quarter ending September 30, 2025, a decrease of -21.27%. This brings the company's revenue in the last twelve months to 777.03M, down -19.93% year-over-year. In the year 2024, Cowealth Medical China had annual revenue of 939.14M, down -14.05%.
Revenue (ttm)
777.03M
Revenue Growth
-19.93%
P/S Ratio
6.68
Revenue / Employee
3.83M
Employees
203
Market Cap
5.19B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 939.14M | -153.46M | -14.05% |
| Dec 31, 2023 | 1.09B | -187.06M | -14.62% |
| Dec 31, 2022 | 1.28B | 88.61M | 7.44% |
| Dec 31, 2021 | 1.19B | 102.04M | 9.37% |
| Dec 31, 2020 | 1.09B | 42.05M | 4.02% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Huadong Medicine | 43.09B |
| WuXi AppTec | 43.07B |
| Yunnan Baiyao Group Co.,Ltd | 40.77B |
| Shanghai Fosun Pharmaceutical (Group) | 39.55B |
| Shenzhen Mindray Bio-Medical Electronics | 33.07B |
| Jiangsu Hengrui Medicine | 30.98B |
| Zhejiang NHU Company | 22.47B |
| Aier Eye Hospital Group | 22.17B |